NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first transcatheter tricuspid valved stent is successfully implanted

Dec 30, 2016   •  Business Wire

LAKE FOREST, Calif., Dec. 30, 2016 — NaviGate Cardiac Structures Inc. ("NCSI") announced today that a novel valved stent that can capture the enlarged annulus in patients suffering from functional tricuspid regurgitation (FTR) was implanted in a patient presenting with massive incompetence of the tricuspid valve. The patient, a 64-year-old female with an extensive history of severe tricuspid…

View Press Release

FOR IMMEDIATE RELEASE - Contact: Ronald Trahan, APR, Ronald Trahan Associates, 1 (508) 359-4005, x108